key: cord-0908129-bxj7rrqv
authors: XING, Yan; HUA, Ying-Rong; SHANG, Jing; GE, Wei-Hong; LIAO, Jun
title: Traditional Chinese medicine network pharmacology study on exploring the mechanism of Xuebijing Injection in the treatment of coronavirus disease 2019
date: 2020-12-31
journal: Chinese Journal of Natural Medicines
DOI: 10.1016/s1875-5364(20)60038-3
sha: 0f45a617ce7e47c4f23631ea402441b548f44e40
doc_id: 908129
cord_uid: bxj7rrqv

As a representative drug for the treatment of severe community-acquired pneumonia and sepsis, Xuebijing (XBJ) injection is also one of the recommended drugs for the prevention and treatment of coronavirus disease 2019 (COVID-19), but its treatment mechanism for COVID-19 is still unclear. Therefore, this study aims to explore the potential mechanism of XBJ injection in the treatment of COVID-19 employing network pharmacology and molecular docking methods. The corresponding target genes of 45 main active ingredients in XBJ injection and COVID-19 were obtained by using multiple database retrieval and literature mining. 102 overlapping targets of them were screened as the core targets for analysis. Then built the PPI network, TCM-compound-target-disease, and disease-target-pathway networks with the help of Cytoscape 3.6.1 software. After that, utilized DAVID to perform gene ontology (GO) function enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis to predict the action mechanism of overlapping targets. Finally, by applying molecular docking technology, all compounds were docked with COVID-19 3 CL protease(3CLpro), spike protein (S protein), and angiotensin-converting enzyme II (ACE2). The results indicated that quercetin, luteolin, apigenin and other compounds in XBJ injection could affect TNF, MAPK1, IL6 and other overlapping targets. Meanwhile, anhydrosafflor yellow B (AHSYB), salvianolic acid B (SAB), and rutin could combine with COVID-19 crucial proteins, and then played the role of anti-inflammatory, antiviral and immune response to treat COVID-19. This study revealed the multiple active components, multiple targets, and multiple pathways of XBJ injection in the treatment of COVID-19, which provided a new perspective for the study of the mechanism of traditional Chinese medicine (TCM) in the treatment of COVID-19.

Novel coronavirus-infected pneumonia (NCIP) was first discovered in Wuhan, Hubei Province, China in December 2019. On March 11, 2020 , the World Health Organization (WHO) declared the 2019 coronavirus disease (COVID-19) is a pandemic [1] . Clinical symptoms such as fever, dyspnea, normal or decreased white blood cell count, organ dysfunction (such as shock, acute heart injury, and acute kidney injury) appear in patients, which can cause death in severe cases [2] . The incubation period of the patients from infection to onset is generally about 5.2 days and approximately 2.3% fatality rate among confirmed cases. Olderly patients as well as patients with other underlying diseases are more likely to die [3, 4] . Due to the high infectivity of the virus, it has a huge negative impact on people's lives and the economic development of the country, but there is still a lack of special drugs and related vaccines [5] . For thousands of years, traditional Chinese medicine (TCM) has accumulated a lot of experience in the treatment of epidemics and has shown a certain effect in the treatment of infectious diseases such as severe acute respiratory syndrome and influenza A virus. Therefore, the National Health Commission and the State Administration of Traditional Chinese Medicine jointly formulated corresponding Chinese medicine diagnosis and treatment plans for the epidemic, and the TCM did show a clinical effect that was not weaker than Western medicine [6, 7] . XBJ injection is the Category 2 of Traditional Chinese Medicines refined from the ancient prescription "Xuefu Zhuyu Decoction ". It is composed of five kinds of TCMs: Safflower (Honghua), Paeoniae Radix Rubra (Chishao), Ligusticum chuanxiong rhizomes (Chuanxiong), Angelica (Danggui), and Salvia miltiorrhiza (Danshen), and is mostly used clinically to treat sepsis [8] , acute lung injury (ALI) [9] , severe pneumonia [10] , multiple organ dysfunction syndrome (MODS) [11] and other critical diseases. Recent studies have shown that XBJ injection can attenuate the excessive production of various inflammatory mediators such as IL-6, TNF-α, MCP-1, MIP-2, and IL-10 in serum and the activation of signaling pathways initiated by Pam3CSK4 [12] , which played a protective role in sepsis mice. Combined with XBJ injection to treat septic shock can improve prognosis by reducing the body's inflammatory response [13] . Besides, XBJ injection can stimulate Treg differentiation in vitro, moderately inhibit Th17 differentiation, prevent cytokine storms, and improve the survival of patients with septic shock to a certain extent [14] . In addition, XBJ injection can prevent inflammatory reaction after Hepato-Pancreato-Biliary surgery and treat rheumatoid arthritis by regulating the inflammatory reactions of the body [15, 16] . In summary, XBJ injection has a significant antiinflammatory effect.

XBJ injection has repeatedly appeared in the national diagnosis and treatment plan for major epidemics [17] . In the published "Diagnosis and Treatment of Novel Coronavirus Pneumonia (Trial Version Fifth, Sixth)" [18, 19] , XBJ injection was listed as one of the treatment measures for severe and critical cases, and it was recommended for the mid-term clinical treatment period and severe stage. For the conventional type of COVID-19 cases, XBJ injection combined with common antiviral treatment could reduce lung lesions, improve the efficacy, and cut down the incidence of severe cases [20] . Long Wen et al. have studied the treatment of 60 severe patients with COVID-19 admitted to the North Hospital of the First Hospital of Changsha City and found that XBJ injection can effectively improve the inflammation markers and prognosis of severe COVID-19 patients [21] . XBJ injection has a positive therapeutic effect on COVID-19 cases, but its underlying mechanism remains unclear.

Network pharmacology is based on the theory of system biology. It constructs an interaction network for drugs, targets, pathways, and diseases, and then analyzes the internal correlation between them by screening key nodes. Therefore, its emphasis is the balance network (or robustness), perturbations in the network, and the biological state of drug effects rather than examining the role of a single or a few scattered targets [22] . The core ideas of the systematization and integrity of network pharmacology are consistent with the characteristics of multi-component, multi-target, and multi mechanism of TCM [23, 24] . It has a wide range of applications in screening active ingredients, explaining the mechanism of drug action, and studying the pathogenesis of diseases [25, 26] .

In this study, we aimed to screen the bioactive ingredients of XBJ injection, clarify its therapeutic targets and path-ways based on a comprehensive network pharmacologybased strategy. In addition, the molecular docking method was also employed to predict the binding mode and affinity of the pharmacologically active compounds and the potential target proteins of COVID-19: 3CLpro, ACE2, and S-protein. This provides a theoretical basis for the in-depth discussion of the pharmacological mechanism of XBJ injection for COVID-19. The procedures of article were shown in Fig. 1 .

The ingredients and the corresponding target genes of XBJ injection were first collected through multiple databases. XBJ injection is composed of 5 kinds of TCM extracts of Honghua, Chishao, Chuanxiong, Danggui, and Danshen. Because of the special nature of the injection, XBJ injection does not contain all the ingredients of these five TCMs. In the early stages, other research groups used UPLC-QTOF/MS and other techniques to identify the composition of XBJ injection [27] [28] [29] Owing to the characteristics of the database, the related targets of some compounds have not been updated or included in time. Accordingly, in the meantime, we searched literatures with the compound name plus "mechanism " or "target " as the keywords in PubMed (https://pubmed. ncbi.nlm.nih.gov). Artificial screening of targets directly affected by compounds shown in recent five-year literatures which were related to the mechanism research about this compound. Targets with unclear meaning and indirect effects of compounds were not adopted. Removed duplicate targets collected from literatures and databases, and applied the Uniprot (http://www.uniprot.org) database to unify the targets into standard gene names. Thus, a target database of compounds was formed.

To construct networks, we next collected target genes related to the COVID-19 disease. The potential targets for COVID-19 were obtained from two resources: the Gene-Cards database (http://www.genecards.org/) and PubMed. GeneCards [30] is a comprehensive bioinformatics database, which provides researchers with platforms and tools to effectively explore human genes, diseases, cells, proteins, etc. Used "Novel Coronavirus Pneumonia" as a keyword to search for potential target genes of COVID-19 in the GeneCards database. Meanwhile, "COVID-19" was applied as a keyword to retrieval in the PubMed database and manually sorted out the COVID-19 related genes in literatures. After that, removed duplicate values and organized these data as a COVID-19 target database. The online Venn diagram tool was employed for identification of the overlapping targets of XBJ injection and COVID-19, thus obtaining the core targets of XBJ injection for COVID-19 treatment.

In order to acquire a deeper understanding of the functions of the obtained core target genes and their roles in the signaling pathway, we imported the screened core targets into the DAVID database (https://david.ncifcrf.gov/home.jsp) and set the corresponding species as "Homo Sapiens". DAV-ID is a bioinformatics database that integrates biological data and analysis tools to associate genes with biological annotations to find the most significantly enriched annotation pathways. Therefore, it can help researchers quickly extract meaningful biological information from large-scale genes [31] . We utilized the Functional Annotation Tool in the DAVID database to obtain Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis results. Sorted according to the "FDR " value and screened out the top ten KEGG and GO results into networks for further study.

Network construction can filter out key nodes from the complex interaction of drugs, target genes and diseases. All networks were visualized in Cytoscape 3.6.1 software. To explain the latent pharmacological mechanism of XBJ injection on the treatment of COVID-19, TCM-compound-target-disease, and disease-target-pathway networks were established. Imported the names of diseases, compounds, core targets, and pathways into Cytoscape 3.6.1 software to separately construct TCM-compound-target-disease and disease-targetpathway networks.

Moreover, the "network analyzer" plug-in was applied to calculate the network topology parameters of the nodes, mainly considering the Betweenness Centrality, Closeness Centrality, and degree. It is generally believed that nodes with larger parameters might be meaningful compounds or targets and act a pivotal part in the entire biological network.

Proteins tend to form macromolecular complexes through interactions to perform biological functions. Proteinprotein interaction (PPI) network analysis helps us study the molecular mechanisms, biological processes, and functions of disease treatment from a systematic perspective. Inputted the overlapping target genes of compounds and disease into the STRING database (https://string-db.org/) to analyze the PPI between the target proteins. Set the organism to "Homo sapiens" and the scoring value (confidence) > 0.7. In order to determine the core targets of XBJ injection for COVID-19 treatment, the obtained PPI network data was imported into Cytoscape 3.6.1 software for further analysis.

The studies have found that the key to the infection of human cells by the novel coronavirus (SARS-CoV-2) is the combination of the coronavirus S protein and the human ACE2 protein, which makes the virus invade the human body and cause disease [32] . 3CLpro is a key protein for viral RNA replication. Inhibiting the function of 3CLpro can block viral replication with a high probability, and indicate the direction for the development of antiviral drugs. The active ingredients in XBJ injection were docked with these three proteins. Meanwhile, drugs (remdesivir, lopinavir, ritonavir) that might be effective for the COVID-19 were considered as positive controls. First, we downloaded the pdb format files (PDB ID: 1R42, 6LU7, 6VSB) of the protein 3D structure from the RSCB PDB database (https://www.rcsb.org/), and applied the Protein Preparation Wizard module in Meastro10.1 software to process them with operations such as hydrogenation and dewater. After that, saved the files as the pdb suffix, and used the Receptor Grid Generation module to generate the grid files for docking. Downloaded the sdf files of the 3D / 2D structure of the active compounds and positive controls from the PubChem database (https://pubchem.ncbi.nlm.nih.gov/), and pretreated ligands with the aid of the Ligprep Preparation module in Meastro10.1 software. Imported the generated protein grid files and the pre-processed ligands into the Ligand Docking module for extra precision (XP) docking. Using docking scores of the positive drugs as the reference values, screened for compounds that were superior to the reference values.

We searched the literature using "XBJ injection constituents" as the keyword. Based on the chemical composition of XBJ injection measured in other studies, we finally determined 45 chemical components with high content, definite bio- logical activity reports, and important pharmacological activities. The information about compounds in each TCM is shown in Table 1 .

Employing the TCMSP, TCMID, ETCM, and Gene-Cards platforms, the known and predicted targets of 45 compounds and COVID-19 were retrieved. Then, through the search of literature, experimentally proven human targets directly affected by 45 compounds and COVID-19 were also included. The original data source is shown in Fig. 2A . The specific target gene data sources of XBJ injection are shown in supplemental file 1, and details of COVID-19 related target genes are shown in supplemental file 2. After removing the duplicate data, a total of 408 targets related to XBJ injection and 265 targets related to COVID-19 were obtained. Among them, XBJ injection and COVID-19 had a total of 102 coincident targets (Fig. 2B) , which became the focus of our follow-up analysis. As shown in Figs. 3A, B, a variety of pathways which related to inflammation and immune response were significantly enriched, such as the TNF signaling pathway, inflammatory bowel disease (IBD) pathway, the Toll-like receptor signaling pathway, the Hypoxia-inducible factor (HIF)-1 signaling pathway, the P13K-AKT signaling pathway, the MAPK signaling pathway, apoptosis, and the Nucleotidebinding oligomerization domain (NOD)-like receptor signaling pathway. The enrichment level of pathways related to 

regulating viral infections was also unignored. Those pathways involved hepatitis B, hepatitis C, influenza A, and Epstein-Barr virus infection. Furthermore, it also showed a certain degree of enrichment in cancer pathways and other infectious lung diseases such as pertussis, tuberculosis. Therefore, we inferred that XBJ injection might be beneficial to the treatment of COVID-19 by regulating inflammation and immune regulation related pathways, viral infection related pathways.

Network construction and analysis Cytoscape 3.6.1 software was employed to draw the TCM-compound-target-disease and disease-target-pathway networks (See Figs. 4A, B) . The TCM-compound-target-disease network comprised a total of 153 nodes (1 disease node, 5 medicinal materials nodes, 42 compound nodes, 105 target nodes) and 599 edges, of which compounds such as danshensu sodium, galloylpaeoniflorin and anhydrosafflor yellow B had not found their corresponding targets. These inter- actions indicated that one compound was able to modulate many targets, and one target was capable of being modulated by multiple compounds simultaneously. According to the node degree parameters of the nodes in the network (shown in was, FDR value, the top 10 KEGG pathways and GO annotation results were added into disease-target-pathway networks. As can be seen from the network, the targets of COVID-19 were coordinated and controlled by multiple pathways. The pathway with the most enriched genes was the pathways in cancer, with 32 genes, followed by the Hepatitis B pathway and extracellular space annotation with 28 genes and 23 genes respectively. PPI network analysis Studying the interaction network between proteins helps to mine the core regulatory genes. Entered 102 overlapping targets related to COVID-19 and XBJ injection into the STRING database to construct the PPI network (See Fig. 5A) . The network had 94 nodes and 779 interaction relationships, with an average degree value of 16.6. Then used Cytoscape 3.6.1 for visual processing, and applied the Degree descending arrangement in the CytoHubba plugin to filter out 40 core targets that were greater than the average degree value. The top ten target proteins are shown in Fig. 5B . Combining PPI network, TCM-compound-target-disease, and disease-targetpathway networks through Merge function in Cytoscape 3.6.1(results see Table 3 ), the results suggested that TNF, MAPK1, IL6, and other genes might play an important role in the treatment of COVID-19.

Molecular docking results revealed that most of the active compounds in XBJ injection had a good binding activity with ACE2, 3CLpro, and S protein. Table 4 docking scores of the three positive drugs, the top three compounds in the network, and the top three compounds with the best binding with the three proteins. The docking results of them are shown in Fig. 6 . The results of molecular docking of all compounds are shown in supplemental file 3. Taking the docking score of the positive drugs as a control, the more negative the score, the better the docking result between the compound and the protein. The top three compounds in the network analysis results, which were quercetin, luteolin, and apigenin, all had similar docking scores as positive drugs but not reached the ideal value. The docking scores of AHSYB, SAB, and rutin were significantly higher than those of the positive control. It demonstrated that the compounds that were not ranked very high in the network may also be the active ingredients of XBJ injection for COVID-19.

Since the outbreak of COVID-19 in December 2019, a total of more than 80 000 people has been diagnosed in China. As of May 11, 2020, there were more than 3 million confirmed cases outside China [33] . The effectiveness of TCM on the treatment of epidemics is well documented. In the SARS period, TCM as a supplementary means made a significant contribution. Moreover, in the treatment of COVID-19, TCM has played a role that cannot be ignored. It has been reported that the use of TCM to treat 102 patients with mild symptoms has shortened the disappearance of clinical symptoms and the recovery time of body temperature. The average length of hospitalization and the incidence of severe cases were significantly reduced, and the improvement rate of CT image was increased [34] .

The initial symptoms of COVID-19 are not obvious, mainly manifested as no symptoms or fever, dry cough, and fatigue. However, about 75% of the patients can develop into serious diseases, which accompanied by dyspnea and severe pulmonary infection, such as acute respiratory distress syndrome (ARDS), sepsis and so on. So, at this stage, the death rate of patients is very high, which is about 15% [35] . XBJ injection is listed as one of the treatment measures for the severe and critical case and a lot of evidence has shown that XBJ injection has a significant anti-inflammatory effect. For instance, XBJ injection is the only Chinese patent medicine approved in China for the treatment of sepsis which can treat sepsis by reducing inflammatory reaction [8, 12] . Meanwhile, ARDS and multiple organ failure in severe patients of COV-ID-19 were reported to be associated with excessive inflammation and cytokine storms [36] . Therefore, XBJ injection may intervene to treat COVID-19 by regulating inflammation and immune response. Among the 5 Chinese herbal medicine ingredients of XBJ injection, the main components of Honghua include apigenin, safflower yellow A, quercetin, etc. It is reported that Honghua can play a pivotal role in the prevention of ALI and other inflammatory lung diseases though regulating Nrf2 [37] . The main components of Chishao are paeoniflorin, paeonol, gallic acid, etc. In particular, paeoniflorin is the most abundant compound in XBJ injection. Paeoniflorin could exert therapeutic effect on sepsis via decreasing plasma sTREM-1 level and inflammatory response [38] . Chuanxiong contains components such as ligustrazine, apigenin, butylphthalide, and so on. Among them, Ligustrazine could ameliorate the inflammatory damage through inhibiting the Rho/ROCK pathway, thereby interfering with the endothelial dysfunction treatment in ALI [39] . Besides, cryptotanshinone, as a component of Danshen, had antitumor activity by inducing the immune response of the body, and also had a certain therapeutic effect on pulmonary fibrosis [40, 41] . In summary, XBJ injection can exert anti-inflammatory effects through a variety of components, which has a significant impact on lung inflammatory diseases. According to the results of network analysis, TNF, MAPK1, and IL-6 might be the crux in the treatment of COVID-19, and all of them were the targets of quercetin, luteolin, and apigenin. IL-6 is a versatile cytokine with a wide range of functions. It has the functions of regulating immune response, acute phase response, and tissue damage, and participates in the anti-infective immune response of the body [42] . Drugs targeting IL-6 or down-regulating IL-6, such as tocilizumab and sarilumab, might be effective in blocking inflammatory storms, so they could become the promising treatment for patients with COVID-19 [43, 44] . Mitogen-activated protein kinase (MAPK) has been reported as a key regulator of ALI [45] . Mechanistically, MAPK1 could achieve the purpose of treating cell injury and lung injury by decreasing cell inflammation and apoptosis. At the same time, studies have suggested that medicines targeting the MAPK3/MAPK1 signaling pathway may has crucial value in the treatment of various inflammatory diseases [46, 47] . Tumor necrosis factor alfa (TNFα) is present in the blood and diseased tissues of patients with COVID-19, and TNFα levels are much higher in patients with severe diseases [42] . TNF could activate IL-6 and IL-1, meanwhile, anti-TNF could decrease leucocyte traffick to inflamed tissues by reducing adhesion molecules and chemokines [48, 49] . Thus TNF, as an essential target, is able to contribute to the immunotherapy of COVID-19 [50, 51] . Besides, in severe patients, serum levels of IL-2, IL-7, IL-10, GSCF, IP10 (CXCL10), MCP1 (CCL2), and MIP1A (CCL3)were significantly higher than that of non-severe patients [35, 52, 53] . Therefore, the ingredients in XBJ injection are capable of subsiding the inflammatory response by reducing the concentration of the following factors in serum: IL-1B, IL-2, IFNG, TNF-α, CXCL10, CCL2, IL10, IL-17, IL-8. KEGG enrichment results showed that TNF, MAPK1, and IL-6 can be enriched to the following pathways: TNF signaling pathway, Influenza A, Tuberculosis, Toll-like receptor signaling pathway, PI3K-Akt signaling pathway, and NOD-like receptor signaling pathway, which suggested that XBJ injection might target IL6, MAPK1, and TNF through quercetin, luteolin, and apigenin, and then affected inflammation, immune regulation, and viral infection related pathways, played an anti-inflammatory effect to treat COVID-19.

The interaction between the viral S protein and ACE2 on the surface of the host cell is important because ACE2 can participate in the regulation of the renin-angiotensin system to trigger lung inflammation. 3CLpro, a viral protease, was regarded as the target of COVID-19 and used to find many potential compounds, such as lopinavir. Therefore, these three are regarded as ideal targets for the treatment of COVID-19 [54] . Among the molecular docking results of all compounds with 3CLpro, S protein, and ACE2, the three compounds with the highest scores were AHSYB, SAB, and rutin. After searching the database, we found that there was little information about the potential target of AHSYB, which indicated that there were few studies on its pharmacological activities. However, with safflor yellow A and hydroxysafflor yellow A, it can ameliorate the lung inflammation and damage caused by lipopolysaccharide through inhibiting the formation of the neutrophil extracellular trap (NET) [55] . SAB, a water-soluble component of Danshen, usually exists in the form of magnesium salt, namely magnesium lithospermate B. It has been reported that magnesium lithospermate B and rosmarinic acid can an exert antiviral effect through reducing the propagate of Enterovirus 71(EV71) particles [56] . In the past studies, rutin, in addition to its well-known antioxidant activity, has shown a good inhibitory effect on hepatitis C virus (HCV), EV71, and other viruses [57, 58] . The above results indicated that AHSYB, SAB, and rutin in XBJ injection might be useful in the treatment of COVID-19 by inhibiting virus invasion and replication.

However, due to the lack of understanding of viruses, disease complications, there are some deficiencies in our study, such as the lack of in-depth research on the predictive ingredients and core targets and pathways. Thus, further investigation and relevant validation in vivo and in vitro are needed.

In this study, network pharmacology and molecular XING Yan, et al. / Chin J Nat Med, 2020, 18(12): 941-951 docking technology were used to explore the potential regulatory mechanism of XBJ injection in the treatment of COV-ID-19. It is suggested that XBJ injection may affect IL-6, TNF, and MAPK1 targets through quercetin, luteolin, and apigenin to inhibit excessive inflammation and cytokine storm caused by COVID-19. The role of XBJ injection involves a variety of biological processes, mainly signaling pathways such as the TNF signaling pathway, Influenza A, Tuberculosis, Toll-like receptor signaling pathway, PI3K-Akt signaling pathway, and so on. Meanwhile, AHSYB, SAB, and rutin suppressed the invasion and replication of novel coronavirus, which will play a role in the treatment of COV-ID-19. It embodies the therapeutic effect of XBJ injection on COVID-19 with the multi-component, multi-target, and multichannel.

Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

What we know so far: COVID-19 current clinical knowledge and research

Traditional Chinese Medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective

Clinical observation on 49 cases of non-critical COVID-19 in Shanghai treated by integrated traditional Chinese and western medicine

Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): protocol for a randomised controlled trial

To explore the preventive and therapeutic effects of Xuebijing injection on acute lung injury induced by cardiopulmonary bypass in rats by regulating the expression of microRNA-17-5p and its mechanism

Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial

Effectiveness of Xuebijing in treatment of multiple organ dysfunction syndrome: a Meta analysis

Xuebijing Injection alleviates Pam3CSK4-induced inflammatory response and protects mice from sepsis caused by methicillin-resistant staphylococcus aureus

Effect of Xuebijing on inflammatory response and prognosis in patients with septic shock

Anti-sepsis protection of Xue

bijing injection is mediated by differential regulation of proand anti-inflammatory Th17 and T regulatory cells in a murine model of polymicrobial sepsis

The preventive effect of Chinese herbal preparation Xuebijing against hyperactive inflammation after hepato-pancreato-biliary surgery

Therapeutic effect of Xuebijing, a Traditional Chinese Medicine Injection, on rheumatoid arthritis

Current evidence and research prospects of Xuebijing Injection in treating novel Coronavirusinfected Pneumonia (COVID-19)

Guidelines on diagnosis and treatment of novel coronavirus pneumonia

Guidelines on diagnosis and treatment of novel coronavirus pneumonia

Clinical observation of Xuebijing in the treatment of COVID-19

Effect of Xuebijing injection on inflammatory markers and disease outcome of coronavirus disease 2019

How can synergism of traditional medicines benefit from network pharmacology

Network pharmacology: the next paradigm in drug discovery

Traditional Chinese medicine network pharmacology: theory, methodology and application

A network pharmacology-based strategy for predicting anti-inflammatory targets of ephedra in treating asthma

Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming

Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS

Chemical profiling and quantification of XueBiJing injection, a systematic quality control strategy using UHPLC-Q Exactive hybrid quadrupole-orbitrap high-resolution mass spectrometry

Simultaneous identification of 20 components in Xuebijing injection by

The genecards suite: from gene data mining to disease genome sequence analyses

DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Coronavirus disease (COVID-19) situation report-111

World Health Organization

Traditional Chinese medicine for COVID-19 treatment

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Study on treatment of "cytokine storm " by anti-2019-nCoV prescriptions based on arachidonic acid metabolic pathway

Carthami Flos suppresses neutrophilic lung inflammation in mice, for which nuclear factorerythroid 2-related factor-1 is required

The effects of paeoniflorin injection on soluble triggering receptor expressed on myeloid-1 (sTREM-1) levels in severe septic rats

Tetramethylpyrazine alleviates LPS-induced inflammatory injury in HUVECs by inhibiting Rho/ROCK pathway

Cryptotanshinone protects against pulmonary fibrosis through inhibiting Smad and STAT3 signaling pathways

Cryptotanshinone has curative dual anti-proliferative and immunotherapeutic effects on mouse Lewis lung carcinoma

Inositol and pulmonary function. Could myo-inositol treatment downregulate inflammation and cytokine release syndrome in SARS-CoV-2?

novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far

Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review

MiR-342 attenuates lipopolysaccharide-induced acute lung injury via inhibiting MAPK1 expression

Effect of PD98059, a se

lective MAPK3/MAPK1 inhibitor, on acute lung injury in mice

Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective antiinflammatory treatment

Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept

Anti-TNF-alpha agents in inflammatory bowel disease and course of COVID-19

CoViD-19 Immunopathology and Immunotherapy

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anticytokine interventions

TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases

Three ingredients of safflower alleviate acute lung injury and inhibit NET release induced by lipopolysaccharide

Magnesium lithospermate B and rosmarinic acid, two compounds present in Salvia miltiorrhiza, have potent antiviral activity against enterovirus 71 infections

Fisetin and rutin as 3C protease inhibitors of enterovirus A71

Identification of a flavonoid isolated from plum (Prunus domestica) as a potent inhibitor of Hepatitis C virus entry